Proanthocyanidins: novel treatment for psoriasis that reduces oxidative stress and modulates Th17 and Treg cells

• Prif Awduron: Rui Lai (Awdur), Dehai Xian (Awdur), Xia Xiong (Awdur), Lingyu Yang (Awdur), Jing Song (Awdur), Jianqiao Zhong (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Taylor & Francis Group, 2018-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Psoriasis is a common, chronic, inflammatory skin disease that affects 2%-4% of the global population. Recent studies have shown that increased oxidative stress (OS) and T-cell abnormalities are central to the pathogenesis of this disease. The resulting reactive oxygen species (ROS) induces prolifer...